Rapidtest.AI
AI reads rapid tests via smartphone to deliver consistent, digital diagnostic results.
Company Overview
Snapshot
Founded in March 2025, Rapidtest.AI operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core technology.
Business overview
Rapidtest.AI is a Health Tech & Life Sciences company specializing in Digital Medical Diagnostics. It is developing an AI-powered computer-vision engine designed to convert standard lateral-flow rapid tests into digital, structured, and shareable diagnostic results. The platform aims to reduce subjective interpretation of rapid tests and enable instant digitization for downstream clinical workflows. The company's technology is being built for integration with healthcare systems, including EHRs, telehealth providers, and pharmaceutical partners, with a focus on privacy and compliance.
Log in to access full profile ›Company Intelligence Q&A
- What is Rapidtest.AI's primary focus?
- Rapidtest.AI focuses on developing an AI-powered computer-vision engine that converts standard lateral-flow rapid tests into consistent, digital diagnostic results via smartphone.
- What problem does Rapidtest.AI aim to solve?
- The company aims to reduce subjective interpretation of rapid test results, such as faint lines, and enable instant digitization for clinical workflows.
- What is the current development stage of Rapidtest.AI's product?
- Rapidtest.AI's product is currently in the Beta stage, meaning it is undergoing testing and refinement before a wider release.
- What markets or industries does Rapidtest.AI serve?
- Rapidtest.AI serves the healthcare industry, with its technology designed for integration with healthcare systems, telehealth providers, and pharmaceutical partners.
- When was Rapidtest.AI founded?
- Rapidtest.AI was founded in March 2025.